Diagnostic or predictive testing for germline mutations in cancer predisposition genes is inherently slow as result of both genetic counselling and mutation analysis. The overall time taken for mutation testing is not generally perceived as harmful to the individual and may be positively beneficial in order to permit full reflection on the implication of the genetic test results. However, we present three cases where we considered urgent genetic testing for the presence of mutations in th BRCA 1 and 2 genes to be necessary as the test result would have altered the subsequent clinical management of these individuals or their families
With advances in genetic research, many experts anticipate an era of “personalized medicine, ” in wh...
Once an incidental finding (IF) is discovered in the course of genomic research, the researchers are...
Mutations in the genes called BRCA1 and BRCA2 are associated with significantly elevated lifetime ri...
Diagnostic or predictive testing for germline mutations in cancer predisposition genes is inherently...
The 21st century is recognized as the age of genetics due to significant discoveries that have revo...
Background: Increasing use of BRCA1/2 testing for tailoring cancer treatment and extension of testin...
AbstractIn this time of amounting cancer incidence and mortality, genetic testing may be greatly val...
Deleterious mutations of the BRCA1 and BRCA2 genes are a major risk factor for the development of br...
Landmark discoveries in the field of breast cancer research include the identification of germline B...
This study sought to investigate the impact of BRCA1 and BRCA2 mutation searching on women previousl...
Identifying germline BRCA pathogenic mutations in patients with ovarian or breast cancer is a crucia...
Identifying germline BRCA pathogenic mutations in patients with ovarian or breast cancer is a crucia...
BRCA1 and BRCA2 are gene mutations that drastically increase chances of developing breast and ovaria...
BRCA1 and BRCA2 mutation carriers have a very highlifetime risk for breast or ovarian cancer. Becaus...
BACKGROUND: Germline pathogenic variants mutations) in the BRCA1 and BRCA2 genes cause an increased ...
With advances in genetic research, many experts anticipate an era of “personalized medicine, ” in wh...
Once an incidental finding (IF) is discovered in the course of genomic research, the researchers are...
Mutations in the genes called BRCA1 and BRCA2 are associated with significantly elevated lifetime ri...
Diagnostic or predictive testing for germline mutations in cancer predisposition genes is inherently...
The 21st century is recognized as the age of genetics due to significant discoveries that have revo...
Background: Increasing use of BRCA1/2 testing for tailoring cancer treatment and extension of testin...
AbstractIn this time of amounting cancer incidence and mortality, genetic testing may be greatly val...
Deleterious mutations of the BRCA1 and BRCA2 genes are a major risk factor for the development of br...
Landmark discoveries in the field of breast cancer research include the identification of germline B...
This study sought to investigate the impact of BRCA1 and BRCA2 mutation searching on women previousl...
Identifying germline BRCA pathogenic mutations in patients with ovarian or breast cancer is a crucia...
Identifying germline BRCA pathogenic mutations in patients with ovarian or breast cancer is a crucia...
BRCA1 and BRCA2 are gene mutations that drastically increase chances of developing breast and ovaria...
BRCA1 and BRCA2 mutation carriers have a very highlifetime risk for breast or ovarian cancer. Becaus...
BACKGROUND: Germline pathogenic variants mutations) in the BRCA1 and BRCA2 genes cause an increased ...
With advances in genetic research, many experts anticipate an era of “personalized medicine, ” in wh...
Once an incidental finding (IF) is discovered in the course of genomic research, the researchers are...
Mutations in the genes called BRCA1 and BRCA2 are associated with significantly elevated lifetime ri...